1. Falk E, Danielsson D, Bjorvatn B, Kristiansen BE, Sørensen B, Melby K. Some phenotypic and genotypic characteristics of prevailing gonococcal strains in Northern Norway. Genitourin Med 1986; 62:9-14.
2. Plasm-leucapheresis or blood exchange in the treatment of meningococcal septicemia. I: K Peter, P lawin, U Jensen (eds): Aktuelle Aspekte in der Intensivmedizin. Springer Verlag, Heidelberg, Berlin, New York. 1986, pp 32-36.
3. Kristiansen BE, Sørensen B, Bjorvatn B, Lindqvist BH, Bryn K, Frøholm LO, Gaustad P, Bøvre K. DNA fingerprinting of Neisseria meningitidis. Antonie van Leeuwenhoek J Microbiol 1986;52:200-201.
4. Flægstad T, Traavik T, Kristiansen BE. Age-dependent prevalence of BK virus IgG and IgM antibodies measured by enzyme-linked immunosorbent assay (ELISA). J Hyg Camb 1986;96:523-8.
5. Flægstad T, Johnsen K, Hvidsten D, Kristiansen BE. Benign meningococcemia with IgG and IgM antimeningococcal antibodies measured by ELISA. Scand J Infect Dis 1987;19:629-633.
6. Andersen BM, Kristiansen BE, et al, Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases. Scand J Infect Dis 1987;19:409-19.
7. Kristiansen BE, Lind K, Mevold K, Sørensen B, Frøholm LO, Bryn K, Tjade T, Bøvre K. Meningococcal phenotypic and genotypic characteristics and human antibody levels. J Clin Microbiol 1988;26:1988-92.
8. Caugant DA, Kristiansen BE, Frøholm LO, Bøvre K, Selander RK. Clonal diversity of Neisseria meningitidis strains isolated from a population of asymptomatic carriers. Infect Immun 1988;52:2060-68.
9. Hekneby A, Rosef O, Ulleren O & Tveten Y. Infiserte kyllingvinger som årsak til smitte med Salmonella typhimurium. Norsk Vet Tidskr 1: 38-39 (1988).
10. Tveten Y, Hagen N, Kristiansen BE, Hopen G, Eng J & Jantzen E. Legionær sykdommen. En aktuell kasuistikk. Tidskr Nor Lægef. 108: 1783-84 (1988).
11. Kristiansen BE, Tveten Y, Ask E, Knapskog AB, Reiten T, Steen-Johnsen J & Hopen G. Miljøundersøkelse ved meningokokksykdom. Tidskr Nor Lægeforen 109: 1373-1376 (1989).
12. Kapperud G, Lassen J, Dommarsnes K, Kristiansen BE, Caugant DA, Ask E, Jahkola M. Comparison of epidemiological marker methods for identification of Salmonella typhimurium isolates from an outbreak caused by contaminated chocolate. J Clin Microbiol 1989;27:2019-24.
13. Kristiansen BE, Jenkins A, Skøld O, Rådstrøm P, Facinelli B. Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis. Antimicrobial Agents and Chemotherapy 1990;34:2277-79.
14. Flægstad T, Gutteberg TJ, Kristiansen BE. Antibodies to meningococci in children with meningococcal disease. Scand J Infect Dis
15. Jenkins A, Kristiansen BE, Ask E, Oskarsen B, Kristiansen E, Lindqvist BH, Trope C, Kjørstad K. Detection of genital papillomavirus types by polymerase chain reaction using common primers. Acta Patologica Microbiologica Immunologica Scandinavica 1991;99:667-673.
16. Kristiansen BE, Ask E, Jenkins A, Fermer C, Rådstrøm P, Skøld O. Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. Lancet 1991;337:1568-9.
17. DNA fingerprinting of isolates of staphylococcus aureus from newborns and their contacts. Tveten Y, Kristiansen BE, Ask E, Jenkins A, and Hofstad T. J Clin Microbiol 1991;29:1100-1105.
18. Rådström P, Fermer C, Kristiansen B-E, Jenkins AJ, Sköld O, & Swedberg G. Transformational exchanges in the dihydropteroate synthase gene of Neisseria meningitidis: a novel mechanism for acquisition of sulfonamide resistance. J Bacteriol 174:6386-6393 (1992).
19. Ask E, Jenkins A, Kærn J, Trope C, & Kristiansen BE. Comparison of HPV detection in parallel biopsies and cervical scrapes by PCR. APMIS. 100:752-756 (1992).
20. Brakstad OG, Mæland JA & Tveten Y. Multiplex polymerase chain reaction for detection of genes for Staphylococcus aurreus thermonuclease and methicillin resistanceand correlation with oxacillin resistance. APMIS 101: 681-688 (1993).
21. Kristiansen BE, Tveten Y, Ask E, Knapskog AB, Reiten T, Steen-Johnsen J & Hopen G. Meningokokkprosjekt Telemark. Tidskr Nor Lægeforen 113: 2933-2937 (1993).
22. Brakstad OG, Tveten Y, Nato F & Fournier JM. Comparison of various methods and reagents for species indentification of Staphylococcus aureus positive or negative for the mecA gene. APMIS 101:651-654 (1993).
23. Kristiansen E, Jenkins A, Kristensen G, Ask E, Kærn J, Abeler V, Lindqvist BH, Tropé C & Kristiansen BE. Human Papillomavirus infection in Norwegian Women with cervical cancer. APMIS 1994; 102: 122-128.
24. Kristiansen E., Jenkins A., & Holm R. Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol 47:253-256 (1994).
25. Tveten Y, Ahlquist J, Krogsvold L, Bruu AL, Størvold G, Ørstarvik I. Restriction endonuclease analysis of adenovirus type 3 isolated in Norway from 1970 to 1971. APMIS 102: 215-218 (1994).
26. Thoresen SI, Jenkins AJ, Ask E. Genetic homogeneity of Taylorella equigenitalis from Norwegian trotting horses revealed by chromosomal DNA fingerprinting. J Clin Microbiol 33:223-234 (1995).
27. Kristiansen BE, Fermér C, Jenkins A, Ask E, Swedberg G and Sköld O. PCR amplicon restriction endonuclease analysis of the chromosomal dhps gene of Neisseria meningitidis: a method for studying the spread of the disease-causing strain in contacts of patients with meningococcal disease. J Clin Microbiol 33:1174-1179 (1995).
28. Tveten Y. Evaluation of new agglutination test for identification of oxacillin-susceptibile and oxacillin-resistant Staphylococcus aureus. J Clin Microbiol 33:1333-1334 (1995).
29. Tveten Y & Kristiansen BE. Typing av Staphylococcus aureus for epidemiologiske formål. Norsk Epidemiologi 5: 32-38 (1995).
30. Kristiansen BE & Tveten Y. Smitteoppsporing of smittesanering ved tilfeller av meningokokksykdom (Meningokokkprosjekt Telemark). Norsk Epidemiologi. 5: 79-83 (1995).
31. Kristiansen BE & Tveten Y. Resistensforhold hos viktige sykdomsfremkallende bakterier. Tidskr Nor Lægefor 115: 2663-68 (1995).
32. Kristensen GB, Karlsen F, Jenkins A, Kærn J, Abeler VM & Tropé CG. Human papillomavirus has no prognostic significance in cervical carcinoma. Eur J Cancer 32A:1349-53 (1996).
33. Jenkins AJ, Kristiansen E, et al. Human papillomavirus in cervical biopsies from Norwegian gynecological in-patients. APMIS 104:30-34 (1996).
34. Jenkins AJ, Kristiansen BE and Kristensen G. Human papillomavirus types in cervical cancer in Norway. Norsk Epidemiologi 5:50-53 (1995).
35. Karlsen F, Kalantari M, Jenkins A, Pettersen E, Kristensen G, Holm R, Johansson B & Hagmar B. Use of multiple PCR-primer sets for optimal human papillomavirus detection. J Clin Microbiol 34:2095-2100 (1996).
36. Bakken JS, Krueth J, Tilden RL, Dumler JS & Kristiansen BE. Serological evidence of human granulocytic ehrlichiosis in Norway. Eur J Clin Microbiol Infect Dis 15: 829-832 (1996)
37. Kristiansen BE, Knapskog AB. Secondary prevention of meningococcal disease. British Medical Journal (editorial). 3 February 1996.
38. Kristiansen BE, Knapskog A-B. Prevention of meningococcal disease. (Authors reply). BMJ 1996;312:1537.
39. Kristiansen BE & Jenkins A. Preventing the spread of meningococcal infection: strategies for chemoprophylaxis. CNS Drugs. Dis Manage Health Outcomes 1:233-240 (1997).
40. Aakre RK, Jenkins A, Kristiansen BE & Frøholm LO. Clonal distribution of invasive Neisseria meningitidis isolates from the Norwegian county of Telemark, 1987 - 1995. J Clin Microbiol. 36: 2623-2628 (1998).
41. Kristiansen BE, Tveten Y & Jenkins A. Contacts of patients with meningococcal disease: Who carries the disease-causing strain? A population based study. Br Med J. 317: 621-5 (1998).
42. Bakken J, Dumler S, Kristiansen BE. Human ehrlichiosis (HGE) - hva er det? Tidsskrift Nor Lægeforen 1998;118:4117-8.
43. Jenkins AJ, Tveten Y, Kristiansen BE. Carriage of meningococci in contacts of patients with meningococcal disease. BMJ 318: 666 (1999).
44. Kristiansen BE & Flægstad T. Guidelines for the diagnosis and treatment of meningococcal disease. Dis Management Health Outcomes. 1999 Feb 5 (2): 73-81.
45. Bjoersdorff A, Berglund J, Kristiansen BE, Søderstrøm C, Eliasson I. Varierende klinisk bild ock forløpp vid human granulocytær ehrlichios. Svenska Lakartidningen 1999; 39:4200-4 (Swedish Medical Journal).
46. Bjoersdorff A, Berglund J, Kristiansen BE; Søderstrøm C, Eliasson I. Human granulocytær ehrlichios: Tolv skandinaviske fall hos menniskar redovisas. Svensk Veterinærtidning 1999;51:29-34. (Swedish Veterinary Journal).
47. Bjoersdorff A, Berglund J, Kristiansen BE, Søderstrøm C, Eliasson I. Varierende klinisk bild ock forløpp vid human granulocytær ehrlichios. Svenska Lakartidningen 1999; 39:4200-4 (Swedish Medical Journal)
48. Jenkins A, Tveten Y, Kristiansen BE. Carriage of meningococci in contacts of patients with meningococcal disease (letter). BMJ 1999;318:66.
49. Harthug S, Digranes A, Hope O, Kristiansen BE, Langeland N. Vancomycin Resistance Emerging in a Clonal Outbreak caused by multiresistant Enterococcus faecium. Clin Microbiol Infect 2000;6:19.28
50. Jenkins A, Handeland K, Stuen S, Schouls L, van de Pol I, Meen RT and Kristiansen BE. Ehrlichiosis in a moose calf in Norway. J Wildl Dis 37: 201-203 (2001).
51. Kristiansen BE. Vaksine mot fattigdom. Tidsskr Nor Legeforen 15: 120 (2000)
52. Grude N. Gule stafylokokker- en kommentar. Utposten 2000; 29: 27
53. Kristiansen BE. Vaksinasjon av verdens fattige - et raskt skritt videre [Vaccination of the poor - a rapid step forward]. J Norwegian Med Ass 2001;121:373.
54. Grude N. Diktspalten. Arne Garborg. pest-POSTEN 2001; 7: 1, 16-17
55. Kristiansen BE, Jenkins A, Tveten Y, Karsten B, Line Ø & Bjöersdorf A. Human granulocytic Ehrlichiosis in Norway. Tidskr Nor Læegeforen 121: 805-806 (2001).
56. Bø K, Rustad L, Harthug S, Akselsen E & Tveten Y. Infeksjonsutbrudd med meticillinresistente gule stafylokokker ved Haukeland sykehus. Tidskr Nor Læegeforen 121: 204-208 (2001).
57. Kristiansen BE, Tveten Y, Vorland L, Sandnes RA, Mortensen L. The prevalence of bacterial resistance in respiratory pathogens in Norway is low. Clin Microbiol Infect In Press. 2001.
58. Grude N, Tveten Y, Kristiansen BE. Urinary tract infection in Norway: bacterial etiology and susceptibility. A retrospective study of clinical isolates. Clin Microbiol Infect. 7: 543-547 (2001).
59. Jenkins AJ, Kristiansen BE, Allum AG, Aakre RK, Strand L, Kleveland EJ, van de Pol I and Schouls L. Borrelia burgdorferi sensu lato and Ehrlichia spp in Ixodes ticks from Southern Norway. J Clin Microbiol. 39: 3666-3671 (2001).
60. Grude N, Stamnes O. Campylobacteriose i tippeligaen. MSIS 2001; 29: 35
61. Grude N, Tveten Y, Torp PØ, Laastad O. Rottebittfeber. Tidsskr Nor Lægeforen 2001; 121: 3057-58
62. Tveten Y, Grude N, Kristiansen B-E. Impetigo bullosa og stafylokokker. MSIS 2001; 29: 40
63. Tveten Y, Jenkins A and Kristiansen BE. A fusidic acid resistant Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother. 50: 873-876 (2002).
64. Tveten Y, Jenkins A, Allum AG, Kristiansen BE and The Norwegian MRSA study group. Heterogeneity of methicillin-resistant Staphylococcus aureus isolated in Norway. Clin Microbiol Infect. 9: 886-892 (2003).
65. Grude N, Tveten Y. Aerococcus urinae og urinveisinfeksjon.Tidsskr Nor Lægefor 2002; 122: 174-75
66. Vainio K, Grude N. Calicivirus og akutt gastroenteritt. Tidsskr Nor Lægefor 2002 122: 2602-04
67. Stamnes O, Grude N. Utbrudd av campylobacteriose blant fotballspillere. Tidsskr Nor Lægefor 2002; 122: 2850-52
68. Grude N, Jenkins A, Tveten Y and Kristiansen BE. Identification of Aerococcus urinae in urine samples. Clin Microbiol Infect. 9: 976-979 (2003).
69. Bretthauer M, Jorgensen A, Kristiansen BE, Hofstad B & Hoff G. Quality control in colorectal cancer: systematic microbiological investigation of endoscopes used in NORCCAPP (Norwegian colorectal cancer prevention) trial. BMC Gastroenterology 3: 15 (2003).
70. Tveten Y, Jenkins A, Digranes A, Melby K, Allum A & Kristiansen BE: Comparison of PCR detection of mecA with agar dilution and E-test for oxacillin susceptibility testing in clinical isolates of coagulase negative staphylococci. Clin Microbiol Infect. 10: 459-470 (2004).
71. Henriksen TH, Lerang F, Lia A, Schøyen R, Thoresen T, Ragnhildstveit E, Tveten Y,
Berstad A. Laboratory handling of Helicobacter pylori critically influences the results of in-vitro metronidazole resistance determination. Clin Microbiol Infect. 10:315-21 (2004).
72. Grude N, Tveten Y, Jenkins A and Kristiansen BE. Uncomplicated urinary tract infections: bacterial findings and efficacy of empirical antibacterial treatment. Scand J Primary Health Care. 23: 115-119 (2005).
73. Robert Skov, on behalf of the SSAC MRSA Working Party: Hans Jørn Kolmos, Reijo
Peltonen, Jaana Vuopio-Varkila, Hjordis Hardardottir, Olafur Gudlaugsson, Stig Harthug, Yngvar Tveten, Barbro Olsson-Liljequist, and Christina Åhrén
MRSA infections increasing in the Nordic countries. Eurosurveillance Weekly 10:3-5 (2005) (http://www.eurosurveillance.org/ew/2005/050804.asp)
74. Kovacevic B, Løkke-Sørensen H, Jenkins A, Allum AG and Kristiansen BE. Normalflora I ytre øregang hos hunder – en mikrobiologisk studie av 40 hunder. Norsk Veterinærtidskrift 117: 177-180 (2005).
75. Kovacevic B. Hvordan kan vi optimalisere antibiotika-bruken i smådyrpraksis. Norsk Veterinærtidsskrift 117: 648-649 (2005).
76. Skudal HK, Grude N & Kristiansen BE. Økende forekomst av antibiotikaresistens ved urinveisinfeksjoner. Tidskr Nor Læegeforen 126: 1058-60 (2006)
77. Grude N, Potaturkina-Nesterova N, Jenkins A, Strand L, Nowrouzian F, Nyhus J & Kristiansen BE. Antibacterial sensitivity, virulence factors and clonal diversity of Escherichia coli from Russian and Norwegian women with urinary tract infection and from healthy women. Clin Microbiol Infect. 13:208-11 (2007)
78. Kovacevic B. Nicoletella semolina - isolert fra Norsk hest med luftveisinfeksjon. Norsk Veterinærtidskrift 119: 259 (2007).
79. Grude N, Kristiansen BE, Sarjomaa M. Et tilfelle av skogflåttencefalitt (TBE) utenfor Agder-fylkene. MSIS 35: 21 (2007).
80. Skaare D, Tveten Y, Kristiansen B-E. Genital Chlamydia – kan vi stole på tallene? Tidsskr Nor Lægeforen 2007; 24: 3232-4.
81. Grude N, Strand L, Mykland H, Nowrozian F, Nyhus J, Jenkins A & Kristiansen BE. Fluoroquinolone resistant uropathogenic Escherichia coli in Norway: evidence of clonal spread. Clin Microbiol Infect: 14: 498-500 (2008).
82. Skov R, Gudlaugsson O, Hardardottir H, Harthug S, Jakobsen T, Kolmos HJ, Olsson-
Liljequist B, Peltonen R, Tveten Y, Vuopio-Varkila J, ÅhrénC. Proposal for common Nordic epidemiologic terms and definitions for methicillin resistant Staphylococcus aureus (MRSA). Scand J Infect Dis. 40: 495-502 (2008).
83. A. W. Friedrich, W Witte, H de Lencastre, W Hryniewicz, J Scheres, H Westh, SeqNet.org participants. A European laboratory network for sequence-based typing of methicillin-resistant Staphylococcus aureus (MRSA) as a communication platform between human and veterinary medicine – an update on SeqNet.org. Eurosurveillance, 13, Issue 19, (2008)
84. Lassen J, Sandven P, Grude N, Hermansen NO and Leegaard T (eds). Strategirapport. Bakteriologisk diagnostikk ved urinveisinfeksjoner. Folkehelseinstituttet, Oslo, 2007.
85. Grude N. Riktig bruk av mikrobiologiske undersøkelser i primærhelsetjenesten. In: Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Antibiotikasenteret for primærmedisin, 2008.
86. Grude N. Kan andre laboratorieundersøkelser hjelpe oss til en bedre antibiotikabehandling?. In: Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Antibiotikasenteret for primærmedisin, 2008.
87. Barheim A and Grude N. Infeksjoner i urinveiene. In: Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Antibiotikasenteret for primærmedisin, 2008.
88. Grude N and Barheim A. Pyelonephritt. In: Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Antibiotikasenteret for primærmedisin, 2008.
89. Barheim A and Grude N. Asymptomatisk uretritt. In: Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Antibiotikasenteret for primærmedisin, 2008.
90. Kristiansen BE, Brandtzæg P, Bjorvatn B and Solberg CO. Meningokokkvaksineforsøket 1988-91. Tidskr Nor Legeforen 129: 192-194 (2009).
..